WPATH Members Privately Discussed Need for Detransition Protocols While Group Faces FTC Lawsuit Over Youth Sex-Change Guidance

The World Professional Association of Transgender Health writes the medical guidelines that shape how doctors across America treat transgender patients, including minors. Those guidelines, called Standards of Care Version 8, inform insurance coverage decisions and government policy nationwide.

Internal messages from a WPATH members-only forum, obtained by The Daily Wire through a public records request, show the group's own members privately acknowledging a gap its public guidance doesn't address: what to do for patients who want to reverse a sex change. The messages span June 2024 to November 2024 and total nearly 250 pages.

What the messages show

Dr. Christopher Terndrup, associate director of the LGBTQ+ Healthcare Fellowship Program at Vanderbilt Health, started a forum thread titled "De-transition Protocols/Policies" asking colleagues whether any institution had formal policies for patients seeking to reverse gender-affirming surgeries or return to their prior hormonal state, according to messages reviewed by The Daily Wire.

Other WPATH members responded describing a real and unmet need. Members reportedly said the absence of formal guidance left detransitioners feeling abandoned by the same medical system that performed procedures like vaginoplasty, breast augmentation, double mastectomy, hysterectomy, and oophorectomy on them.

The organization's public materials do not include standardized protocols for detransition care, even as detransitioners have increasingly spoken out publicly about complications and regret following pediatric or young-adult transition.

The legal backdrop

The private discussion comes as WPATH faces direct legal scrutiny. The Federal Trade Commission filed a lawsuit against the organization in June 2026, alleging WPATH "misled parents and children about the medical consensus and medical necessity, as well as the safety and effectiveness" of sex-change interventions for minors, according to the FTC's complaint. That is a legal allegation, not a proven fact, and WPATH has not been found liable in court as of this writing.

Separately, independent systematic reviews of the evidence behind SOC-8 have raised methodological concerns. England's National Health Service commissioned the Cass Review, led by Dr. Hilary Cass, which found the evidence supporting pediatric medical transition to be of low quality and led the NHS to restrict puberty blockers for minors outside of clinical trials. Critics of WPATH's methodology argue the SOC-8 process involved political pressure on authors, a claim WPATH has disputed publicly in the past.

The strongest case for WPATH's position

WPATH and its defenders have argued that gender-affirming care, including for minors in some cases, is supported by major U.S. medical groups such as the American Academy of Pediatrics and the Endocrine Society, and that regret rates following transition are low according to some published studies. They argue detransition, while real and deserving of care, represents a small fraction of patients, and that building out formal detransition protocols is a reasonable next step for a relatively young and still-evolving field of medicine, not evidence the underlying model of care is flawed.

A medical field acknowledging it needs better protocols for a subset of patients is not automatically an admission the entire framework is broken. Fields evolve. Detransition research is genuinely newer and thinner than research on transition itself.

Where that argument runs into trouble

The problem is what WPATH says publicly versus what its own members say privately. Publicly, WPATH's Standards of Care do not include detransition protocols despite the organization existing for decades and detransitioners raising concerns for years. Privately, per these forum messages, its own clinicians in 2024 were asking basic questions, essentially starting from scratch, about how to care for patients whose bodies had already been altered.

For minors, the question is particularly acute. They cannot easily reverse the effects of cross-sex hormones, double mastectomies, or surgical sterilization. If WPATH's own membership didn't have a shared protocol for undoing harm as of late 2024, that's a relevant fact for any parent, doctor, or insurer relying on WPATH's Standards of Care to make decisions about a child today.

What happens next

The FTC's lawsuit against WPATH remains in litigation as of July 2026, and no verdict has been reached. The Daily Wire has said additional installments of its investigative series, drawn from the same forum records, are forthcoming. Whether WPATH updates its Standards of Care to formally address detransition, and whether the FTC case produces findings of fact about what the organization knew and when, are pending.